BARCLAYS PLC - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$8,000
+33.3%
7,347
+33.0%
0.00%
Q2 2021$6,000
-80.0%
5,523
-82.6%
0.00%
Q1 2021$30,00031,654
+28940.4%
0.00%
Q3 2019$0
-100.0%
109
-99.9%
0.00%
Q1 2019$364,000
+230.9%
172,557
+254.3%
0.00%
Q4 2018$110,000
+1733.3%
48,700
+2764.7%
0.00%
Q1 2018$6,000
-98.7%
1,700
-98.4%
0.00%
Q4 2017$466,000
+5725.0%
106,041
+3627.3%
0.00%
Q2 2016$8,0002,8450.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BARD ASSOCIATES INC 124,300$87,0000.04%
Hayden Royal, LLC 16,000$12,272,0000.01%
Global Strategic Investment Solutions, LLC 23,000$16,0000.01%
Founders Capital Management 8,000$6,0000.01%
Cable Hill Partners, LLC 20,000$14,0000.00%
Jacobi Capital Management LLC 25,000$18,0000.00%
Stonebridge Capital Advisors LLC 22,000$15,0000.00%
B. Riley Wealth Advisors, Inc. 37,520$27,0000.00%
Firestone Capital Management 5,200$4,0000.00%
MGO ONE SEVEN LLC 10,615$7,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders